Juvenile Idiopathic Arthritis-The Rubik's Cube of Pediatric Rheumatology

Olcay Y Jones1,2, Deborah K McCurdy3, Charles H Spencer4

  • 1Division of Pediatric Rheumatology, Department of Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.

PubMed

Insights

This review offers a practical framework for recognizing, monitoring, and managing Juvenile Idiopathic Arthritis (JIA) in children. It aids clinicians in early diagnosis and effective treatment of JIA subtypes for better patient outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Autoimmune Diseases
  • Clinical Practice Guidelines

Background:

  • Juvenile Idiopathic Arthritis (JIA) is the most common pediatric autoimmune rheumatic disease.
  • Varied presentations across JIA subtypes necessitate precise diagnosis and intervention.
  • Early management is crucial for optimal growth, development, and preventing long-term disability.

Purpose of the Study:

  • To present a clinically practical framework for JIA recognition, monitoring, and management.
  • To synthesize evidence-based knowledge with clinical experience for daily decision-making.
  • To support clinicians in accurate JIA diagnosis and treatment strategies.

Main Methods:

  • Narrative literature review.
  • Incorporation of real-world academic rheumatology clinical experience.
  • Development of a structured, stepwise evaluation approach for suspected JIA.

Main Results:

  • A framework integrating pattern recognition and differential diagnosis for JIA evaluation.
  • Emphasis on joint involvement (peripheral vs. axial) and extra-articular manifestations (uveitis, cutaneous, GI).
  • Highlights distinctive features of major JIA subtypes and principles for monitoring and treatment.

Conclusions:

  • The structured approach facilitates accurate JIA recognition and subtype differentiation.
  • Aids in early diagnosis and provides insights for improved patient management.
  • Emphasizes the importance of multidisciplinary care for enhanced patient outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
473
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K